Beforpharma at EANM 2024 in Hamburg

The Beforpharma team participated in the European Association of Nuclear Medicine (EANM) Congress held in Hamburg, Germany, from October 19 to 23. This prestigious event attracted nearly 9,000 professionals in the field of nuclear medicine. Throughout the congress, Beforpharma engaged in scientific sessions and had the opportunity to connect with both current and prospective partners.

It was a vibrant gathering where leading experts, researchers, and clinicians shared their latest findings and innovations. The event featured a wide array of presentations, symposiums, and poster sessions that highlighted cutting-edge advancements in nuclear medicine. Attendees had the opportunity to network with peers, exchange ideas, and explore potential collaborations.

The lively discussions and dynamic atmosphere at the congress underscored the importance of continued research and development in nuclear medicine, promising exciting breakthroughs for the future.